Techbio that industrializes the discovery of new natural molecules for drug discovery.
| Date | Round | Amount |
|---|---|---|
| Apr 2026 | Series A Paris-based Generare closed a EUR 20M Series A co-led by Alven and Daphni to produce 10x more new molecules by 2027. | $23.2M |
| Oct 2024 | Seed French biotech Generare raised a €5M seed from Teampact.ventures, Galion.Exe and VIVES Partners to discover medicines hidden in soil bacteria. | $5.4M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.